cbdMD (NYSEAMERICAN:YCBD) Trading Down 1.1% – What’s Next?

cbdMD, Inc. (NYSEAMERICAN:YCBD)’s share price dropped 1.1% on Friday . The company traded as low as $0.69 and last traded at $0.6951. Approximately 227,107 shares changed hands during mid-day trading, an increase of 55% from the average session volume of 146,633 shares. The stock had previously closed at $0.7030.

cbdMD Trading Down 1.1%

The company has a 50-day moving average price of $0.78 and a 200-day moving average price of $0.88.

cbdMD (NYSEAMERICAN:YCBD) last released its quarterly earnings data on Thursday, May 14th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). cbdMD had a negative net margin of 13.29% and a negative return on equity of 33.60%. The business had revenue of $5.64 million during the quarter, compared to analysts’ expectations of $5.29 million.

Institutional Investors Weigh In On cbdMD

A hedge fund recently bought a new position in cbdMD stock. Jane Street Group LLC acquired a new position in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned about 0.49% of cbdMD as of its most recent filing with the Securities & Exchange Commission. 7.18% of the stock is owned by hedge funds and other institutional investors.

About cbdMD

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.